Scalp treatment for reducing hair shedding and regrowing hair
Treatments studied
Part of Skin clinical trials.
This study tests a new scalp product called DA-001 to see if it reduces hair shedding and helps hair grow back in people with telogen effluvium. It's a clinical trial that compares the treatment to a placebo (a product without the active ingredient) to find out if it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with telogen effluvium (a type of hair shedding that usually happens after stress or a change in your body).
- You are willing to apply the study treatment as directed and attend all study visits.
- You are generally healthy (no serious medical conditions that could affect the study).
- You are not pregnant, planning to become pregnant, or breastfeeding during the study.
- You have not had a major medical event (like a heart attack or stroke) in the last 90 days, and you haven't used prescription scalp treatments or had scalp surgery in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two new topical treatments for hereditary hair loss. It may help you regrow hair or slow further thinning.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
This study tests if a topical solution with dutasteride can help regrow hair in men with androgenetic alopecia (male pattern baldness). It might slow hair loss and promote new growth, giving a non-invasive option.
This trial tests if a special drinkable supplement can help prevent or reduce hair loss in women who are taking a GLP-1 or GIP receptor agonist (a type of weight-loss or diabetes medication). The study looks for women who have just started this medication or have been on it for less than 3 months.
This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.
This study tests a new scalp solution (KX-826) for men with androgenetic alopecia, commonly known as male pattern baldness. It aims to see if the solution can help regrow hair and is safe to use. Participants will apply the solution to their scalp and have their hair growth monitored over time.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.